09/11/2026 - General information
As part of the organization's 50th anniversary, dedicated to providing comprehensive support to people with chronic kidney disease and promoting organ donation. Hospital del Mar's work in the diagnosis, care and treatment of people with chronic kidney disease, as well as its work in the field of kidney transplantation, particularly living-donor transplantation, was recognized during the 50th anniversary of the Ader Foundation. The hospital received one of the awards presented by the organization at the event commemorating its half-century of activity, held on October 18 at the CosmoCaixa Barcelona auditorium. The event, 'Prevention, Personalization, Dialysis, Donation and Kidney Transplantation', featured the participation of leading professionals in the field, including Dr. Marta Crespo, Head of the Nephrology Department at Hospital del Mar and researcher at the Hospital del Mar Research Institute.
13/10/2026 - General information
Research in the field of frailty and kidney transplantation, led by the Nephrology and Physical Medicine and Rehabilitation Departments at Hospital del Mar and researchers from the Hospital del Mar Research Institute, has received the Nephrology Research Award at the Íñigo Álvarez de Toledo Awards for Nephrology Research, presented by the Spanish Kidney Foundation. The award jury, made up of 22 experts in nephrology, research and business, granted two awards: one for nephrology and another for nephrology nursing, which, in this edition, was shared by two projects.
21/05/2026 - Institutional news
The grants will support three research projects in the field of sarcopenia in people with chronic respiratory diseases, the application of phage therapy in lung disease caused by non-tuberculous mycobacteria, and lung cancer screening. The grants will be presented on 6 June during SEPAR's 59th congress. The scientific committee for the SEPAR 2026 grants call has awarded three grants to projects led by professionals from the Hospital del Mar Pneumology Department and researchers from the Hospital del Mar Research Institute (HMRIB). Overall, this grant call from the Sociedad Española de Neurmología y Cirugía Torácica has distributed more than 600,000 euros to promote research.
08/05/2026 - Press release
An international collaborative study, published in the Journal of Experimental Medicine, highlights the role of immunoglobulin D (IgD) in the processes involved in generating tolerance to antigens and bacteria that live in our body. The study characterizes, for the first time, the cells that produce these antibodies and identifies their point of origin in the tonsils. These results open the door to the possibility of developing drugs and vaccines focused on this type of antibody, both for the treatment of allergies and other diseases linked to inflammation
Més informació "Researchers identify one of the mechanisms that may regulate allergen tolerance"
27/02/2026 - Press release
High levels of this protein, which is part of blood cholesterol, are associated with a 40% higher probability of multivessel coronary atherosclerosis, directly linked to the risk of heart attack or other cardiac events. The findings come from a study led by researchers at the Hospital del Mar Research Institute and published in the American Journal of Preventive Cardiology. The authors advocate measuring lipoprotein(a) levels in all patients, not only those at high cardiovascular risk. This can be done through a simple blood test.
05/02/2026 - Press release
Infections caused by Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii are identified as priorities for clinical research. The study, published in the Journal of Infection and Public Health, involved 60 experts who reached consensus on the main priorities for the development of new clinical trials. The work carried out within the MePRAM project of CIBER has resulted in several priority lists-microorganisms, clinical syndromes, patient populations and anti-infective treatments-aimed at guiding future research from a personalised medicine approach.
Més informació "The roadmap for clinical research against antibiotic resistance established"
11/12/2025 - Press release
The research team led by the Institut de Recerca Joan de Déu (IRSJD) and the Hospital del Mar Research Institute has, for the first time, demonstrated the efficacy of a drug in animal models developed from samples of patients from the Sant Joan de Déu Hospital. The study identifies the PRKG1 gene as a key element in the biology of rhabdomyosarcoma and as a potential biomarker to predict treatment response. The determination of Cristina's parents-a girl who passed away from rhabdomyosarcoma in 2015-has been crucial in making this study possible. Their commitment enabled the raising of more than €600,000 to promote research into new treatments for this type of pediatric tumor.
25/11/2025 - Institutional news
Dr. César Jessé Enríquez has received the award for the best oral presentation in the area of the CIBER of Respiratory Diseases (CIBERES) during the Joint Training Days between the CIBER area of Respiratory Diseases (CIBERES) and the CIBER area of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), focused on early-career researchers. The event took place at Euroforum El Escorial on November 6 and 7.
Més informació "Award for César Jessé Enríquez at the joint training days of CIBER-BBN and CIBERES"
04/11/2025 - General information
The Pharmacokinetics and Pharmacodynamics (PK/PD) Research Team at Hospital del Mar has received a competitive international grant awarded by the pharmaceutical company Pfizer, as part of the "Independent Research Grant Program - Pharmacokinetics-pharmacodynamics (PK/PD) of Aztreonam-Avibactam (ATM-AVI) in Special Populations." The selected project, chosen among proposals from several European centers, aims to optimize the use of the new antibiotic aztreonam-avibactam in patients with renal impairment - a population particularly vulnerable to severe infections caused by multidrug-resistant bacteria. The project is led by Dr. Mila Montero and Dr. Sònia Luque.
Més informació "Pfizer International Grant for a Project at Hospital del Mar on Antibiotic Therapy"
22/10/2025 - General information
The Hemodynamics Unit of the Cardiology Department at Hospital del Mar took part in a study published in the New England Journal of Medicine. The study demonstrates that one month after undergoing treatment for a myocardial infarction, patients can safely continue therapy with a single antiplatelet drug without added risk.
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
